in

Ajanta Pharma Q3 Results: Net Profit Up 11% At Rs 233 Crore

Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Larsen & Toubro Confident Of Achieving FY25 Guidance On Strong Order Visibility: CFO

Paradeep Phosphate To Invest Rs 4,000 Crore In Odisha